PCAR vs RVPH · P/E 25, rev $33.66B vs $7.6M cap
PACCAR Inc (PCAR) versus Reviva Pharmaceuticals Holdings Inc. (RVPH) — a side-by-side from cached financials, not a winner call.
PACCAR Inc (PCAR) is a farm & heavy construction machinery company listed on NASDAQ.
Reviva Pharmaceuticals Holdings Inc. (RVPH) is a biotechnology company listed on NASDAQ.
Latest reported PCAR revenue for 2024-12-31 was $33.66B. Net income was $4.16B. Revenue was down 4.2% from 2023-12-31 to 2024-12-31. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
RVPH does not have a complete income-statement cache yet.
PCAR currently screens at market cap $61.75B and trailing P/E 25.0. RVPH currently screens at market cap $7.6M.
Not investment advice. Open the PCAR and RVPH stock pages for the full models.
Not investment advice.